Gsα signalling suppresses PPARγ2 generation and inhibits 3T3L1 adipogenesis

Since TSH receptor (TSHR) expression increases during adipogenesis and signals via cAMP/phospho-cAMP-response element binding protein (CREB), reported to be necessary and sufficient for adipogenesis, we hypothesised that TSHR activation would induce preadipocyte differentiation. Retroviral vectors introduced constitutively active TSHR (TSHR*) into 3T3L1 preadipocytes; despite increased cAMP (RIA) and phospho-CREB (western blot) there was no spontaneous adipogenesis (assessed morphologically, using oil red O and QPCR measurement of adipogenesis markers). We speculated that Gβγ signalling may be inhibitory but failed to induce adipogenesis using activated Gsα (gsp*). Inhibition of phosphodiesterases did not promote adipogenesis in TSHR* or gsp* populations. Furthermore, differentiation induced by adipogenic medium with pioglitazone was reduced in TSHR* and abolished in gsp* expressing 3T3L1 cells. TSHR* and gsp* did not inactivate PPARγ (PPARG as listed in the HUGO database) by phosphorylation but expression of PPARγ1 was reduced and PPARγ2 undetectable in gsp*. FOXO1 phosphorylation (required to inactivate this repressor of adipogenesis) was lowest in gsp* despite the activation of AKT by phosphorylation. PROF is a mediator that facilitates FOXO1 phosphorylation by phospho-Akt. Its transcript levels remained constantly low in the gsp* population. In most measurements, the TSHR* cells were between the gsp* and control 3T3L1 preadipocytes. The enhanced down-regulation of PREF1 (adipogenesis inhibitor) permits retention of some adipogenic potential in the TSHR* population. We conclude that Gsα signalling impedes FOXO1 phosphorylation and thus inhibits PPARγ transcription and the alternative promoter usage required to generate PPARγ2, the fat-specific transcription factor necessary for adipogenesis.

[1]  O. MacDougald,et al.  Inhibitor of DNA binding 2 is a small molecule-inducible modulator of peroxisome proliferator-activated receptor-gamma expression and adipocyte differentiation. , 2008, Molecular endocrinology.

[2]  K. Moelling,et al.  Akt‐ and Foxo1‐interacting WD‐repeat‐FYVE protein promotes adipogenesis , 2008, The EMBO journal.

[3]  A. Tchernof,et al.  Hypertrophy and hyperplasia of abdominal adipose tissues in women , 2008, International Journal of Obesity.

[4]  D. Fuhrer,et al.  Biological effects of thyrotropin receptor activation on human orbital preadipocytes. , 2006, Investigative ophthalmology & visual science.

[5]  Hui Chen,et al.  FOXO1 Represses Peroxisome Proliferator-activated Receptor-γ1 and -γ2 Gene Promoters in Primary Adipocytes , 2006, Journal of Biological Chemistry.

[6]  H. Sul,et al.  Pref-1 (Preadipocyte Factor 1) Activates the MEK/Extracellular Signal-Regulated Kinase Pathway To Inhibit Adipocyte Differentiation , 2006, Molecular and Cellular Biology.

[7]  Hui Chen,et al.  FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. , 2006, The Journal of biological chemistry.

[8]  Richard G. Jenner,et al.  Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Ludgate,et al.  Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo. , 2003, Journal of molecular endocrinology.

[10]  D. Accili,et al.  The forkhead transcription factor Foxo1 regulates adipocyte differentiation. , 2003, Developmental cell.

[11]  M. Lane,et al.  Mitotic clonal expansion: A synchronous process required for adipogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Reusch,et al.  CREB Activation Induces Adipogenesis in 3T3-L1 Cells , 2000, Molecular and Cellular Biology.

[13]  C. Remacle,et al.  Various stimulators of the cyclic AMP pathway fail to promote adipose conversion of porcine preadipocytes in primary culture. , 1999, Differentiation; research in biological diversity.

[14]  J. Auwerx,et al.  Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[15]  B. Spiegelman,et al.  Posttranscriptional Control of Adipocyte Differentiation through Activation of Phosphoinositide 3-Kinase* , 1998, The Journal of Biological Chemistry.

[16]  L. Jan,et al.  Molecular Basis for Interactions of G Protein βγ Subunits with Effectors , 1998 .

[17]  M Ivan,et al.  An amphotropic retroviral vector expressing a mutant gsp oncogene: effects on human thyroid cells in vitro. , 1997, The Journal of clinical endocrinology and metabolism.

[18]  Bruce M. Spiegelman,et al.  Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ , 1996, Science.

[19]  L. Lin,et al.  Functional expression of thyrotropin receptor in differentiated 3T3-L1 cells: a possible model cell line of extrathyroidal expression of thyrotropin receptor. , 1996, Biochemical and biophysical research communications.

[20]  J. French,et al.  The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey , 1995, Clinical endocrinology.

[21]  B. Spiegelman,et al.  PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene , 1995, Molecular and cellular biology.

[22]  H. Sul,et al.  Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation , 1993, Cell.

[23]  J. Parma,et al.  The thyrotropin receptor and the regulation of thyrocyte function and growth. , 1992, Endocrine reviews.

[24]  Hsien-yu Wang,et al.  Antisense oligodeoxynucleotides to Gs protein α-subunit sequence accelerate differentiation of fibroblasts to adipocytes , 1992, Nature.